Nootropics Index - Save on smarter supplements
Isolated phytochemicals & plant compounds

Hordenine

Hordenine (N,N-dimethyltyramine)

Hordenine is a plant-derived phenethylamine alkaloid; Hordenine HCl is its hydrochloride salt. Small human studies describe absorption, not demonstrated focus, energy or fat-loss benefits. No effective nootropic dose or cycle is established. Compare the exact form and verified package weight before using price per gram, and read the U.S. supplement-status note before buying.

DopaminergicAdrenergicIsolated CompoundMostly Animal EvidenceMostly In Vitro EvidenceInsufficient EvidenceForm Dependent Evidence
Updated October 2026/6 min read/11 citations
Reviewed by the NootropicsIndex editorial team.Method: prioritize cited human research and official safety or regulatory sources; compare retailer-listed prices without endorsing products.Affiliate disclosure
01

What is it?

Hordenine and its HCl form

1

Hordenine is also called N,N-dimethyltyramine. The free base and hydrochloride salt are distinct chemical forms; their package masses are not interchangeable. A barley or bitter-orange extract is not the same product as isolated hordenine.

Human exposure is not proof of a benefit5
A four-person beer study measured absorption and metabolism. It did not test focus, energy or motivation, and food exposure cannot establish the safety of concentrated powders.
02

Names, aliases and forms

Common NamesHordenine; Cactine
Chemical NamesN,N-Dimethyltyramine; 4-[2-(dimethylamino)ethyl]phenol
Salt FormHordenine HCl
Research CodeK3489CA082
Taxonomic SynonymAnhaline
Molecular FormulaC10H15NO
Cas Number539-15-1
InchikeyKUBCEEMXQZUPDQ-UHFFFAOYSA-N
03

Mechanisms of action

Dopamine findings are preclinical

7

Hordenine activated dopamine D2 signaling in cells and was studied in mouse and nematode models. Those experiments do not show that an oral supplement improves cognition or motivation in healthy people.

Why blood exposure matters

11

A 2025 modeling study compared receptor potency with predicted exposure. Such extrapolation helps prioritize research but is not a clinical trial: neither receptor activation nor a model-derived dose proves benefit or a rate of harm in users.

04

Potential effects and evidence map

Grade E for healthy-user benefits. Human studies are small pharmacokinetic investigations; receptor and animal findings do not establish improved attention, motivation or performance. These data do not define an effective or safe routine supplement regimen.

Effect domainMagnitudeGrade
Mental energy / wakefulness8
UnknownConfidence: Low

An energy or wakefulness benefit has not been established in controlled human outcome studies.

Note A zero score indicates no established human benefit, not proof that an effect is impossible.

0/5
E
Focus / attention8
UnknownConfidence: Low

Small human absorption studies do not establish a focus or attention benefit.

0/5
E
Motivation / drive7
UnknownConfidence: Low

Dopamine-receptor findings in preclinical models do not establish improved motivation in people.

0/5
E
Physical energy / endurance8
UnknownConfidence: Low

Hordenine-specific performance and endurance benefits remain unestablished.

0/5
E
05

Typical dosages and timing

Single study exposure8100 mg

A pilot study gave three healthy men aged 25-30 one fasted oral capsule dose. This was an absorption study, not an effective-dose or safety trial. The report does not establish that the dose is equivalent to the same labeled mass of HCl powder.

06

Timing & effect horizon

Effect horizonUnknown
Unknown
Plasma peak8Acute
65 minutes
Plasma half-life8Acute
54 minutes
Blood timing is not effect duration8

The three-person capsule study reported a mean plasma peak at 65 minutes and a mean elimination The time for blood levels to fall by half during the final elimination phase.Source of 54 minutes, with substantial variation. These describe measured blood concentrations, not onset of a focus benefit, time to redose or a safe interval between uses.

07

Safety, side effects and risk profile

Why the precautionary risk rating is moderate9
For isolated oral products, OPSS warns of possible raised blood pressure and rapid heart rate. These potentially meaningful effects warrant more caution than a low rating, but their human likelihood, dose threshold and reversibility are unquantified. High would overstate the mainly animal and mechanistic evidence. This rating is not a safety assurance for any dose or duration.
Legal / regulatory risk3
Confidence: High

As of 2026-10-12, FDA warning letters identify U.S. dietary-supplement products containing hordenine HCl as adulterated.

Note U.S. product-category restriction; not a global legal conclusion or an adverse-event rate.

4/5
C
Cardiovascular caution9
Confidence: Low

OPSS flags possible rapid heart rate and raised blood pressure with oral hordenine; the evidence is largely from animals.

Note Precautionary concern with potentially meaningful consequences. Human incidence, threshold dose and reversibility are not quantified.

3/5
D
Interaction risk10
Confidence: Low

A safe stimulant or medication combination has not been established; adrenergic receptor activity gives a mechanistic reason for caution.

Note No proven interaction magnitude or safe stacking schedule is inferred from cell assays.

2/5
D
Pregnancy / lactation caution8
Confidence: Low

The cited oral supplement study did not include pregnant or breastfeeding people.

Note Absence of safety evidence for these populations; not evidence of a measured reproductive hazard.

2/5
E
Evidence uncertainty8
Confidence: High

The small single-dose study does not establish routine-use safety or an effective regimen.

Note Do not translate a research exposure into a recommended dose or cycle.

2/5
E
Who the human data do not cover8

The single-dose capsule study involved only three young adult men. It does not establish safety during pregnancy or breastfeeding, in children, in people with cardiovascular conditions, or with repeated long-term use. A detailed list of common side effects cannot be derived from this study.

08

Interactions and cautions

No validated stacking schedule10

Laboratory activation of adrenergic receptors provides a reason to question combinations with other stimulants or medicines affecting blood pressure. Direct human interaction data do not establish a safe combination, dose adjustment or separation interval. Receptor findings alone cannot quantify clinical interaction risk.

10

How it compares

HCl powder versus extracts and blends6

Compare like-for-like HCl products first. An extract or blend may list a total serving weight without disclosing its hordenine content; that weight cannot be used as grams of hordenine. Do not assume synephrine, octopamine and hordenine share the same evidence or regulatory status.

11

Practical buying and quality notes

  • For comparable HCl powders, divide the total price by the verified net weight in grams, then consider shipping and currency. Some listed offers have inconsistent package quantities or zero normalized prices. Verify the merchant label before comparing; a zero unit price is not a free offer.
  • Look for the exact salt form, an identified batch and a certificate of analysis that states what was measured. An analysis of bitter-orange/amine products found labeling discrepancies and undeclared synthetic amines. That supports checking composition; it does not establish a problem with any particular offer shown here.6
12

FAQ

Does dopamine-receptor activity mean it improves focus?

7

No human focus benefit follows automatically from receptor activity. The cited dopamine research used cells and animal models; it cannot establish an effective nootropic product or dose.

What matters most when comparing HCl offers?

1

Use the same chemical form, a verified net package weight and the final delivered price. Check the actual label and batch documentation when catalog quantities disagree. Package size describes what is sold, not a validated serving size.

Is there an evidence-based dosage or cycle?

8

No regimen was validated by the small human studies cited here. A one-time research exposure does not establish an effective daily dose, a safe repeat interval, tolerance management or a cycle length.

13

References

  1. PubChem Compound Summary for CID 68313, Hordenine.
  2. U.S. FDA. Information on Select Dietary Supplement Ingredients and Other Substances: Hordenine and Hordenine HCl.
  3. U.S. FDA Warning Letter: SCS Direct, Inc. 633509. April 6, 2023.
  4. World Anti-Doping Agency. The Prohibited List.
  5. Sommer T, Goen T, Budnik N, Pischetsrieder M. Absorption, Biokinetics, and Metabolism of the Dopamine D2 Receptor Agonist Hordenine (N,N-Dimethyltyramine) after Beer Consumption in Humans. J Agric Food Chem. 2020;68:1998-2006.
  6. Pawar RS, Sagi S, Leontyev D. Analysis of bitter orange dietary supplements for natural and synthetic phenethylamines by LC-MS/MS. Drug Test Anal. 2020;12:1241-1251.
  7. Li H, Gao M, Chen Z, et al. Hordenine improves Parkinsonian-like motor deficits in mice and nematodes by activating dopamine D2 receptor-mediated signaling. Phytother Res. 2023;37:3296-3308.
  8. Sobiech M, Giebultowicz J, Lulinski P. Application of Magnetic Core-Shell Imprinted Nanoconjugates for the Analysis of Hordenine in Human Plasma-Preliminary Data on Pharmacokinetic Study after Oral Administration. J Agric Food Chem. 2020;68:14502-14512.
  9. Operation Supplement Safety (OPSS). Hordenine in Dietary Supplements: Why Avoid It? Updated March 7, 2022.
  10. Pinckaers NET, Blankesteijn WM, Mircheva A, et al. In Vitro Activation of Human Adrenergic Receptors and Trace Amine-Associated Receptor 1 by Phenethylamine Analogues Present in Food Supplements. Nutrients. 2024;16:1567.
  11. Pinckaers NET et al. Quantitative in vitro-to-in vivo extrapolation of human adrenergic and trace amine-associated receptor 1 potencies of pre-workout supplement ingredients using physiologically based kinetic modelling-based reverse dosimetry. Archives of Toxicology. 2025;99:1999-2021.
Note

This page is informational and summarizes available evidence. It is not medical advice, a recommendation, or a substitute for guidance from a qualified clinician.